Researchers have identified CD43, a sugar-coated protein on the surface of leukemia cells, as a key mechanism the cancer uses to evade immune system detection. The heavy sugar coating on CD43 forms a physical barrier that shields leukemia cells from immune attack, functioning as a disguise that helps the cancer dodge the body's defenses. This discovery explains why leukemia has proven resistant to many of the newest generation of cancer immunotherapies, which rely on the immune system to recognize and attack cancer cells. The finding represents a significant advance in understanding leukemia's immune evasion strategies and could point toward new therapeutic targets.
CD43 Protein's Sugar Coating as Immune Shield
- ▪CD43 protein on leukemia cells is coated heavily in sugar molecules
- ▪Leukemia cells have a protein called CD43 on their surface
- ▪The sugar coating on CD43 protein forms a physical barrier that shields leukemia cells from immune attack
- ▪CD43 protein is a key part of leukemia's disguise from the immune system
Implications for Cancer Immunotherapy Resistance
- ▪Leukemia is resistant to many of the newest generation of cancer immunotherapies
- ▪Leukemia is adept at dodging the immune system
Perspective of Cancer immunotherapy researchers
- ▪The CD43 sugar coating mechanism explains why leukemia resists modern immunotherapy treatments
- ▪Understanding how CD43 shields leukemia cells from immune detection could enable development of new therapeutic approaches
Story comments
Loading comments…